Apr. 17 at 4:48 PM
$TTOO (part 3) Speculation only as a possibility.
Contribution to a possible T2MR Consortium as licensee (AI Gemini Speculation DD req'd.)
8. Roche Following the SAGA/Foundation Medicine acquisition (April 16), Roche provides the Digital Standard. They connect T2MR results to global MRD (Minimal Residual Disease) databases.
9. bioMérieux a Regulatory Shield.
10. Vizient, Inc. As the largest Group Purchasing Organization, they provide the Contract Access. They ensure that 97% of academic medical centers can buy the T2MR panels at pre-negotiated volume prices.
11. Waters Corp Molecular Validator
Provides the Mass Spectrometry (MS) Backbone. While T2MR detects the presence of a pathogen or tumor cell, Waters tech quantifies the metabolic response of the patient, acting as a "Calibration Tool" ensures the Radiopharmaceutical Tenants (Lilly/Bayer) are delivering the exact dosage required based on the real-time blood chemistry reported by the T2MR.
(AI Gemini Speculation your DD req'd.)
..
